*Rei Yokoyama1,2, Yukio Ago2, Hisato Igarashi1, Momoko Higuchi1, Masato Tanuma1, Yuto Shimazaki1, Kaoru Seiriki1, Misuzu Hayashida1, Shun Yamaguchi3,4, Hirokazu Tanaka5, Takanobu Nakazawa6, Kenji Hashimoto7, Atsushi Kasai1,8, Hitoshi Hashimoto1,9,10,11,12
(1. Lab. Mol. Neuropharmacol., Grad. Sch. Pharmaceut. Sci., Osaka Univ., Osaka, Japan, 2. Dept. Cell. Mol. Pharmacol., Grad. Sch. Biomed. Health Sci., Hiroshima Univ., Hiroshima, Japan, 3. Dept. Morph. Neurosci., Grad. Sch. Med., Gifu Univ., Gifu, Japan, 4. Ctr. One Med. Innov. Transl. Res., Inst. Adv. Study, Gifu Univ., Gifu, Japan, 5. Fac. Info. Technol., Tokyo City Univ., Tokyo, Japan, 6. Dept. Biosci., Tokyo Univ. Agri., Tokyo, Japan, 7. Div. Clin. Neurosci., Chiba Univ. Ctr. Forensic. Mental Hlth., Chiba, Japan, 8. Sys. Brain Sci. Project, Drug Innov. Ctr., Grad. Sch. Pharmaceut. Sci., Osaka Univ., Osaka, Japan, 9. Mol. Res. Ctr. Children’s Mental Dev., United Grad. Sch. Child Dev., Osaka Univ., Osaka, Japan, 10. Inst. Datability Sci., Osaka Univ., Osaka, Japan, 11. Inst. Open Transdiscip. Res. Initiatives, Osaka Univ., Osaka, Japan, 12. Dep. Mol. Pharmaceut. Sci., Grad. Sch. Med., Osaka Univ., Osaka, Japan)
キーワード:Depression , Ketamine, (R)-ketamine, Social isolation
抄録パスワード認証
抄録本文の閲覧にはパスワードが必要です。以下のパスワードをご入力の上、ご利用ください。
PW: Neuro2024